Glen Eagle Advisors’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-21
| Closed | -$10K | – | 955 |
|
|
2021
Q3 | $10K | Sell |
21
-4
| -16% | -$1.91K | ﹤0.01% | 697 |
|
|
2021
Q2 | $11.8K | Buy |
25
+8
| +47% | +$3.77K | ﹤0.01% | 663 |
|
|
2021
Q1 | $11.7K | Buy |
17
+2
| +13% | +$1.37K | ﹤0.01% | 637 |
|
|
2020
Q4 | $11.1K | Buy |
15
+13
| +650% | +$9.61K | ﹤0.01% | 616 |
|
|
2020
Q3 | $1.08K | Hold |
2
| – | – | ﹤0.01% | 839 |
|
|
2020
Q2 | $1.33K | Buy |
+2
| New | +$1.33K | ﹤0.01% | 791 |
|